Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an average...
WASHINGTON (Reuters) -The Biden administration on Thursday sought to ramp up its pandemic response following U.S. detection of the Omicron coronavirus variant this week, making...
A confluence of the widespread adoption of digital innovations, accelerating developments in therapeutics, and rising healthcare spending should propel the healthcare...
We’ve just hit the best time of the year to roll out one of our most potent dividend “hacks.” Timed just right, it’ll deliver us stout payouts yielding...
This week is a big one for earnings, not just because of the big names reporting but because of the large number of earnings announcements. Investors can expect the themes of...
Yesterday, stocks advanced for the 6th day heading towards previous highs as earnings rolled in. With little economic news on the calendar, there was little to worry traders...
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Buy | Neutral | Strong Buy | Strong Buy | Strong Buy |
| Summary | Neutral | Neutral | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 165.32 | 167.88 | 164.28 | +3.48 | +2.15% | 102.59M | NASDAQ | |||
| 37.52 | 37.86 | 36.75 | +0.63 | +1.71% | 424.65K | NYSE | |||
| 317.87 | 320.10 | 306.35 | +11.03 | +3.59% | 21.24M | NASDAQ | |||
| 2,863.10 | 2,876.90 | 2,803.00 | +23.1 | +0.81% | 1.37M | NASDAQ | |||
| 3,427.37 | 3,473.91 | 3,338.69 | +37.58 | +1.11% | 3.35M | NASDAQ | |||
| 51.49 | 53.90 | 51.25 | -2.78 | -5.12% | 44.84M | NYSE | |||
| 300.37 | 302.40 | 280.38 | -6.56 | -2.14% | 62.92M | NASDAQ | |||
| 9.94 | 10.23 | 9.20 | +0.65 | +7.00% | 3.02M | NASDAQ | |||
| 123.60 | 123.82 | 113.43 | +11.64 | +10.40% | 41.79M | NYSE | |||
| 57.47 | 58.18 | 56.83 | +0.99 | +1.75% | 1.79M | NYSE | |||
| 127.58 | 127.99 | 117.50 | +2.89 | +2.32% | 1.05M | NYSE | |||
| 6.15 | 6.22 | 5.70 | +0.470 | +8.27% | 7.55M | NASDAQ | |||
| 10.17 | 10.49 | 10.00 | -0.26 | -2.49% | 2.06M | NASDAQ | |||
| 38.49 | 38.69 | 35.44 | +2.64 | +7.36% | 36.61M | NYSE | |||
| 202.74 | 204.22 | 197.78 | +6.42 | +3.27% | 10.47M | NYSE |